BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38229252)

  • 1. Elevated prostate-specific antigen (PSA) levels from acute COVID-19 infection confounding cancer disease surveillance.
    Tan YJ; Tan Y
    QJM; 2024 Jun; 117(5):378-379. PubMed ID: 38229252
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen level association with COVID-19 infection and vaccination.
    Frumer M; Aharony SM; Shoshany O; Kedar D; Baniel J; Golan S
    Clin Genitourin Cancer; 2023 Dec; 21(6):e405-e411. PubMed ID: 37270370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of the COVID-19 pandemic on early detection of prostate cancer in Australia.
    Ip CCK; Kealey J; Davis ID; Sengupta S
    BJU Int; 2021 Dec; 128 Suppl 3(Suppl 3):6-8. PubMed ID: 34750958
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of prostatic specific antigen in men with prostate disease. An elevated PSA level may indicate prostate cancer--and it may not.
    Wozniak-Petrofsky J
    Geriatr Nurs; 1993; 14(3):150-1. PubMed ID: 7685308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes.
    Cooperberg MR; Brooks JD; Faino AV; Newcomb LF; Kearns JT; Carroll PR; Dash A; Etzioni R; Fabrizio MD; Gleave ME; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Lin DW; Zheng Y
    Eur Urol; 2018 Aug; 74(2):211-217. PubMed ID: 29433975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
    Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
    Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen and the early diagnosis of prostate cancer.
    Caplan A; Kratz A
    Am J Clin Pathol; 2002 Jun; 117 Suppl():S104-8. PubMed ID: 14569806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated results from the European Randomized Study of Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: are Asian countries encouraged to promote PSA screening?
    Sugimoto M; Kakehi Y
    Asian J Androl; 2012 Jul; 14(4):522-4. PubMed ID: 22751444
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of examination of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hyperplasia and prostate cancer.
    Romics I; Frang D; Bodrogi I
    Int Urol Nephrol; 1997; 29(4):449-55. PubMed ID: 9406003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexed prostate-specific antigen improvement in detecting prostate cancer.
    Okihara K; Babaian RJ
    Curr Urol Rep; 2001 Jun; 2(3):253-8. PubMed ID: 12084274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
    Faisal FA; Sundi D; Pierorazio PM; Ball MW; Humphreys EB; Han M; Epstein JI; Partin AW; Carter HB; Bivalacqua TJ; Schaeffer EM; Ross AE
    BJU Int; 2014 Dec; 114(6b):E120-E129. PubMed ID: 24731026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between PSA values and surveillance quality after prostate cancer surgery.
    Chapman CH; Caram MEV; Radhakrishnan A; Tsodikov A; Deville C; Burns J; Zaslavsky A; Chang M; Leppert JT; Hofer T; Sales AE; Hawley ST; Hollenbeck BK; Skolarus TA
    Cancer Med; 2019 Dec; 8(18):7903-7912. PubMed ID: 31691526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there still a role for digital rectal examination in the prostate cancer diagnostic pathway in the COVID-19 and post COVID-19 era?
    Tan WS; Wong A; Mahmalji W; Raza A
    Aging Male; 2021 Dec; 24(1):92-94. PubMed ID: 34319201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
    Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer.
    Boddy JL; Pike DJ; Al-Hayek S; Shaida N; Malone PR
    Prostate Cancer Prostatic Dis; 2005; 8(4):349-52. PubMed ID: 16010283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen and prostate cancer.
    Rosalki SB; Rutherford FJ
    Int J Clin Pract; 2000 Nov; 54(9):611-3. PubMed ID: 11220990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.
    Jansen FH; van Schaik RH; Kurstjens J; Horninger W; Klocker H; Bektic J; Wildhagen MF; Roobol MJ; Bangma CH; Bartsch G
    Eur Urol; 2010 Jun; 57(6):921-7. PubMed ID: 20189711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients.
    Iremashvili V; Manoharan M; Lokeshwar SD; Rosenberg DL; Pan D; Soloway MS
    BJU Int; 2013 Mar; 111(3):396-403. PubMed ID: 22703025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
    Becker C; Noldus J; Diamandis E; Lilja H
    Crit Rev Clin Lab Sci; 2001 Oct; 38(5):357-99. PubMed ID: 11720279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostatic specific antigen in practice in 1997].
    Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
    Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.